JOHN HOPE FRANKLIN CENTER
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1838-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.duke.edu
Retisert and Cataract Surgery in Patients With Severe Uveitis
- Conditions
- Intermediate UveitisPosterior Uveitis
- Interventions
- Device: Retisert (fluocinolone acetonide implant)
- First Posted Date
- 2007-12-11
- Last Posted Date
- 2014-09-03
- Lead Sponsor
- Duke University
- Target Recruit Count
- 21
- Registration Number
- NCT00570830
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
Neurocognitive Outcomes of Depression in the Elderly
- Conditions
- Major DepressionDementia
- First Posted Date
- 2007-12-11
- Last Posted Date
- 2020-08-05
- Lead Sponsor
- Duke University
- Target Recruit Count
- 795
- Registration Number
- NCT00570583
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
Feasibility of Cocooning Immunization Strategy With Influenza Vaccine
- Conditions
- Influenza
- Interventions
- Biological: Trivalent inactivated influenza vaccine
- First Posted Date
- 2007-12-10
- Last Posted Date
- 2013-06-24
- Lead Sponsor
- Duke University
- Target Recruit Count
- 544
- Registration Number
- NCT00570037
- Locations
- 🇺🇸
Durham Regional Hospital, Durham, North Carolina, United States
🇺🇸Duke University Hospital, Durham, North Carolina, United States
Utility of Exercise-induced N-terminal (NT) Pro-brain Natriuretic Peptide Levels in Predicting Prognosis in Asymptomatic Aortic Stenosis
- Conditions
- Aortic Stenosis
- Interventions
- Other: NT-pro-BNP levels
- First Posted Date
- 2007-12-05
- Last Posted Date
- 2012-10-24
- Lead Sponsor
- Duke University
- Target Recruit Count
- 110
- Registration Number
- NCT00567437
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
Sorafenib and Isolated Limb Infusion of Melphalan in Treating Patients With Stage III Melanoma of the Arm or Leg
- Conditions
- Melanoma (Skin)
- Interventions
- Genetic: gene expression analysisGenetic: protein expression analysisGenetic: western blottingOther: pharmacological study
- First Posted Date
- 2007-11-30
- Last Posted Date
- 2015-03-06
- Lead Sponsor
- Duke University
- Target Recruit Count
- 20
- Registration Number
- NCT00565968
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Phase II Study Evaluating The Safety And Response To Neoadjuvant Dasatinib In Early Stage Non-Small Cell Lung Cancer
- First Posted Date
- 2007-11-28
- Last Posted Date
- 2015-02-23
- Lead Sponsor
- Duke University
- Target Recruit Count
- 2
- Registration Number
- NCT00564876
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
KAN-DO: A Family-based Intervention to Prevent Childhood Obesity
- Conditions
- ObesityPostpartum PeriodPrevention & Control
- Interventions
- Behavioral: KAN-DO
- First Posted Date
- 2007-11-26
- Last Posted Date
- 2014-07-11
- Lead Sponsor
- Duke University
- Target Recruit Count
- 832
- Registration Number
- NCT00563264
- Locations
- 🇺🇸
Duke University Dept. of Community and Family Medicine, Durham, North Carolina, United States
🇺🇸UNC Greensboro, Greensboro, North Carolina, United States
Adjuvant Cisplatin With Either Genomic-Guided Vinorelbine or Pemetrexed for Early Stage Non-Small-Cell Lung Cancer
- Conditions
- Carcinoma, Non-Small-Cell Lung
- Interventions
- First Posted Date
- 2007-10-18
- Last Posted Date
- 2014-07-21
- Lead Sponsor
- Duke University
- Target Recruit Count
- 31
- Registration Number
- NCT00545948
- Locations
- 🇺🇸
Palm Beach Cancer Institute, West Palm Beach, Florida, United States
🇺🇸Maria Parham Hospital, Henderson, North Carolina, United States
🇺🇸Presbyterian HealthCare, Charlotte, North Carolina, United States
Phase II Dasatinib Study in Advanced Breast Cancer
- First Posted Date
- 2007-10-18
- Last Posted Date
- 2013-07-17
- Lead Sponsor
- Duke University
- Target Recruit Count
- 31
- Registration Number
- NCT00546104
- Locations
- 🇺🇸
Palm Beach Cancer Center Institute, West Palm Beach, Florida, United States
🇺🇸Duke University Medical Center, Durham, North Carolina, United States
🇺🇸Presbyterian Health Care, Charlotte, North Carolina, United States
Re-implantation of a Fluocinolone Acetonide Implant for Non-infectious Uveitis Affecting the Posterior Segment
- Conditions
- Uveitis
- Interventions
- Drug: 0.59 mg Fluocinolone Acetonide implant
- First Posted Date
- 2007-10-12
- Last Posted Date
- 2015-03-31
- Lead Sponsor
- Duke University
- Target Recruit Count
- 21
- Registration Number
- NCT00543296
- Locations
- 🇺🇸
Duke University Eye Center, Durham, North Carolina, United States